BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 36187930)

  • 21. Differential Expression of the
    Hu J; Xu J; Feng X; Li Y; Hua F; Xu G
    Front Cell Dev Biol; 2021; 9():700661. PubMed ID: 34631699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Significance of Chr9p22.1-p21.3 Deletion in Cancer Development: A Pan-cancer
    Gonçalves PG; Reis RM; Bidinotto LT
    Anticancer Res; 2022 Nov; 42(11):5291-5304. PubMed ID: 36288884
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioinformatics and survival analysis of glia maturation factor-γ in pan-cancers.
    Lan A; Ren C; Wang X; Tong G; Yang G
    BMC Cancer; 2021 Apr; 21(1):423. PubMed ID: 33863293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single-cell analysis of multiple cancer types reveals differences in endothelial cells between tumors and normal tissues.
    Zhang J; Lu T; Lu S; Ma S; Han D; Zhang K; Xu C; Liu S; Gan L; Wu X; Yang F; Wen W; Qin W
    Comput Struct Biotechnol J; 2023; 21():665-676. PubMed ID: 36659929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Good or not good: Role of miR-18a in cancer biology.
    Kolenda T; Guglas K; Kopczyńska M; Sobocińska J; Teresiak A; Bliźniak R; Lamperska K
    Rep Pract Oncol Radiother; 2020; 25(5):808-819. PubMed ID: 32884453
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Pan-Cancer Analysis of the Oncogenic Role of
    Yang D; Li H; Chen Y; Li C; Ren W; Huang Y
    Front Genet; 2022; 13():906174. PubMed ID: 35910232
    [No Abstract]   [Full Text] [Related]  

  • 27. Pan-cancer analysis reveals the pro-oncogenic role of N6-methyladenosine (m6A)-regulated NTMT1 in head and neck squamous cell carcinoma.
    Zhao C; Yu M; Li Y
    J Biochem Mol Toxicol; 2024 Jan; 38(1):e23603. PubMed ID: 38014887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systematic pan-cancer analyses of the potential function of the Golgi scaffold protein PAQR3.
    Ling ZN; Hong LL; Wu J; Ling ZQ
    Sci Rep; 2024 Feb; 14(1):3030. PubMed ID: 38321173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comprehensive pan-cancer analysis of the expression characteristics, prognostic value, and immune characteristics of
    Fei L; Lu Z; Xu Y; Hou G
    Front Genet; 2022; 13():920897. PubMed ID: 36035140
    [No Abstract]   [Full Text] [Related]  

  • 30. Pan-Cancer Analysis Revealed
    Liu J; Wang Y; Yin J; Yang Y; Geng R; Zhong Z; Ni S; Liu W; Du M; Yu H; Bai J
    J Oncol; 2022; 2022():3477148. PubMed ID: 35069733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MARCO is a potential prognostic and immunotherapy biomarker.
    Dong Q; Zhang S; Zhang H; Sun J; Lu J; Wang G; Wang X
    Int Immunopharmacol; 2023 Mar; 116():109783. PubMed ID: 36773567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pan-Cancer Analysis on the Oncogenic Role of Programmed Cell Death 10.
    Sun N; Li C; Teng Y; Deng Y; Shi L
    J Oncol; 2022; 2022():1242658. PubMed ID: 36276268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comprehensive Bioinformatic Investigation of TP53 Dysregulation in Diverse Cancer Landscapes.
    Khan R; Pari B; Puszynski K
    Genes (Basel); 2024 Apr; 15(5):. PubMed ID: 38790205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein profiling reveals potential isomiR-associated cross-talks among RNAs in cholangiocarcinoma.
    Guo L; Dou Y; Yang Y; Zhang S; Kang Y; Shen L; Tang L; Zhang Y; Li C; Wang J; Liang T; Li X
    Comput Struct Biotechnol J; 2021; 19():5722-5734. PubMed ID: 34745457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pan-Cancer Integrated Analysis Identification of SASH3, a Potential Biomarker That Inhibits Lung Adenocarcinoma Progression.
    Chen X; Yuan Y; Ren W; Zhou F; Huang X; Pu J; Niu X; Jiang X
    Front Oncol; 2022; 12():927988. PubMed ID: 35756681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioinformatics analysis of prognostic value and immunological role of MeCP2 in pan-cancer.
    Wang Y; Zhang Y; Wang F; Li T; Song X; Shi H; Du J; Zhang H; Jing H; Han J; Tong D; Zhang J
    Sci Rep; 2022 Nov; 12(1):18518. PubMed ID: 36323715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pan-cancer analysis of necroptosis-related gene signature for the identification of prognosis and immune significance.
    Ma J; Jin Y; Gong B; Li L; Zhao Q
    Discov Oncol; 2022 Mar; 13(1):17. PubMed ID: 35312867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A pan-cancer analysis of the role of argininosuccinate synthase 1 in human tumors.
    Ding Q; Li R; Wang Q; Yu L; Zi F
    Front Oncol; 2023; 13():1049147. PubMed ID: 38053661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of PRDM1 in Tumor Immunity and Drug Response: A Pan-Cancer Analysis.
    Shen L; Chen Q; Yang C; Wu Y; Yuan H; Chen S; Ou S; Jiang Y; Huang T; Ke L; Mo J; Feng Z; Zhou P; Fan W
    Front Pharmacol; 2020; 11():593195. PubMed ID: 33384601
    [No Abstract]   [Full Text] [Related]  

  • 40. The function of guanylate binding protein 3 (GBP3) in human cancers by pan-cancer bioinformatics.
    Jiang T; Jin P; Huang G; Li SC
    Math Biosci Eng; 2023 Mar; 20(5):9511-9529. PubMed ID: 37161254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.